Fact-checked by Grok 2 weeks ago

DailyMed

DailyMed is a free online database operated by the of Medicine (NLM), a component of the (NIH), that serves as the official provider of (FDA) label information for marketed drugs and other regulated products. Launched in November 2005 in cooperation with the FDA, it offers a standardized, comprehensive, and up-to-date resource for accessing electronic drug labeling to support safe and effective use by healthcare professionals, patients, and researchers. The database contains labeling submitted directly to the FDA by manufacturers, including prescribing information, patient medication guides, Drug Facts labels, and carton or container labeling, available in HTML, PDF, and XML formats for easy lookup and download. DailyMed covers a wide range of FDA-approved products, such as prescription and nonprescription drugs for human and animal use, biological products, medical devices, and medical gases, as well as additional categories like unapproved drugs, , dietary supplements, and medical foods. It receives daily updates from the FDA's Labeling (SPL) files, ensuring the content reflects the most current "in use" labeling, though NLM does not independently verify the accuracy of the submitted information. Key features include advanced search capabilities by drug name, , or National Drug Code (NDC); and integration with other NLM resources like for broader health information. By August 2006, shortly after its launch, DailyMed had already incorporated its 500th drug label, highlighting its rapid growth as a vital tool in and drug safety education.

Overview

Purpose and Mission

DailyMed serves as a public resource dedicated to providing free and up-to-date access to product labeling submitted to the (FDA) by manufacturers, enabling informed decision-making for healthcare professionals, patients, researchers, and caregivers. Its core objective is to disseminate accurate, scientifically grounded information on medications, including prescription drugs, over-the-counter products, biologics, and certain medical devices, in accessible formats such as , PDF, and XML. The platform supports safe and effective use by making critical details readily available, such as drug indications, recommended dosages, contraindications, warnings, potential adverse reactions, and interactions. This information empowers users to mitigate risks, adhere to proper administration guidelines, and understand therapeutic benefits, thereby enhancing overall and outcomes. Operated by the National Library of Medicine (NLM), part of the National Institutes of Health (NIH), it functions as a centralized repository where labeling updates from manufacturers' submissions, including those under "Changes Being Effected" supplements, are posted promptly to reflect the most current information without prior FDA endorsement.

Operator and Governance

DailyMed is operated by the National Library of Medicine (NLM), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The NLM manages the platform as a public service to disseminate authoritative drug labeling information, aligning with its broader role in providing free access to biomedical and health-related data. DailyMed collaborates closely with the (FDA) to facilitate the electronic submission and validation of Structured Product Labeling (SPL) files from pharmaceutical companies. These submissions ensure that the database reflects labeling for FDA-regulated products, though NLM does not review or alter the content prior to publication. Funding for DailyMed comes primarily through federal appropriations allocated to the NIH, which supports NLM's operations without imposing direct user fees on the public or submitters. This model sustains the platform's availability as a no-cost resource for healthcare providers, researchers, and consumers. The governance structure integrates technical oversight by NLM's Office of Computer and Communications Systems (OCCS), which handles system maintenance, development, and infrastructure for applications including DailyMed. Content oversight is provided by the appropriate FDA centers, which regulate the accuracy and compliance of submitted labels for their respective product categories prior to integration into the database.

History

Establishment and Early Development

DailyMed was established in November 2005 through a collaboration between the National Library of Medicine (NLM) and the (FDA), launching as the official public repository for electronic drug labeling to meet the growing need for accessible, standardized information. This initiative preceded the FDA's Physician Labeling Rule, finalized in January 2006 and effective June 2006, which mandated revised content and format requirements for labels to enhance clarity for healthcare providers. DailyMed's beta version began with the transmission of its first label on November 1, 2005, focusing initially on to facilitate the shift toward electronic dissemination. The platform's early development emphasized the adoption of the Structured Product Labeling (SPL) format, an HL7-approved standard that the FDA required for electronic submissions starting in 2006 to ensure consistent, machine-readable drug data. Initial efforts centered on prescription drugs, with the database reaching its 500th label by August 2006, demonstrating rapid growth in content availability. DailyMed marked a pivotal transition from the FDA's static print-based resources, such as paper package inserts, to a dynamic enabling real-time updates and broader accessibility for clinicians and patients. This evolution supported ongoing collaboration between NLM and FDA to ensure content reliability through annual label reviews and approvals.

Key Milestones and Updates

In 2009, DailyMed introduced a product identification system to assist users in identifying solid medications, such as tablets and capsules, by searchable attributes including imprint, color, shape, size, and scoring, which complemented existing searches via National Drug Codes (NDC) for enhanced accuracy. The platform launched a mobile-optimized version on January 31, 2011, enabling on-the-go access to over 20,000 structured product labels at the time, thereby broadening its reach to healthcare professionals and consumers using portable devices. A major website redesign occurred on September 18, 2014, featuring a responsive design that improved usability across devices and incorporated enhanced search functionalities, with subsequent updates in 2015 adding options for Unique Ingredient Identifiers (UNII) codes and inactive ingredients to facilitate more precise queries. By 2025, DailyMed had expanded to include over 154,000 drug labels, reflecting ongoing growth through the continued partnership with the FDA for label submissions, and featured annual updates such as those for vaccines tailored to the 2025-2026 season. DailyMed integrated feeds to provide notifications for label updates and additions, allowing users to subscribe for real-time alerts, alongside bulk download capabilities that offer periodic releases of all labels in format for comprehensive data access.

Content and Scope

Types of Information Provided

DailyMed provides a range of labeling and documentation essential for the safe and effective use of pharmaceutical products. The core content includes Prescribing Information (PI), which offers a comprehensive summary of scientific data for healthcare professionals on approved prescription drugs and biologics, encompassing critical elements such as boxed warnings. labeling delivers FDA-approved labeling tailored for patients, families, or caregivers, including formats like Patient Information leaflets, Medication Guides, and Instructions for Use to support understanding and adherence. For over-the-counter (OTC) products, Drug Facts labels present standardized information on active ingredients, uses, warnings, directions, and inactive ingredients in an accessible format. Additionally, carton and container labeling is included to highlight key safety details from the point of dispensing through administration. Within these labels, specific sections detail vital pharmacological and clinical aspects. The Indications and Usage section outlines the approved therapeutic applications of the drug. Dosage and Administration provides precise instructions on dosing regimens and methods of delivery. Contraindications specify conditions or patient groups where the drug is not recommended. Warnings and Precautions address potential risks, monitoring needs, and preventive measures. Adverse Reactions describe observed side effects and their frequencies. Drug Interactions identify substances or conditions that may alter the drug's efficacy or safety. Use in Specific Populations covers considerations for vulnerable groups, such as pregnant individuals, nursing mothers, pediatric, geriatric, or renally impaired patients. explains the drug's , , , and related studies. To enable precise identification and searching, DailyMed incorporates standardized indexing terms, including the (UNII) assigned by the joint FDA/ Substance Registration System () for active ingredients and moieties. These codes facilitate accurate cross-referencing of substances across labels. All submissions are formatted using Structured Product Labeling (SPL), an XML-based standard developed by the FDA to ensure consistent, machine-readable representation of label content. This format supports both human-readable displays and programmatic access to the information. The database encompasses labeling for both and products, extending these informational categories to veterinary applications.

Coverage of Products and Categories

DailyMed encompasses a wide array of FDA-regulated products, primarily focusing on those marketed in the United States through the submission of Labeling (SPL) files by manufacturers and labelers. This includes prescription and nonprescription drugs for use, encompassing biologics, generics, and brand-name medications, as well as drugs intended for veterinary applications. Biologics, such as and blood products, are integrated into the database alongside traditional small-molecule drugs, reflecting the FDA's unified oversight of pharmaceutical and biological entities. Beyond pharmaceuticals, DailyMed extends to additional categories like medical gases, certain medical devices, , dietary supplements, and medical foods, providing labeling information for these regulated items even when they fall outside full FDA approval pathways. For instance, and dietary supplements, which are not subject to pre-market approval but must adhere to labeling regulations, are included if SPL submissions are provided to the FDA. Medical foods, designed for of specific conditions, and medical gases, such as oxygen for therapeutic use, further broaden the scope to support diverse healthcare needs. The database covers both FDA-approved products and unapproved ones where labeling has been voluntarily submitted, including categories like unapproved drugs, homeopathic products, and certain medical gases not evaluated for and . This inclusion ensures access to current labeling for items in the U.S. market, though it does not represent a complete inventory of all FDA-regulated products, as non-submitted labels are excluded. As of July 2025, DailyMed hosts over 154,000 active labels, with discontinued or withdrawn products archived separately for historical reference. These labels typically detail critical elements such as warnings, interactions, and usage instructions to aid safe application across categories.

Features and Access

Search Capabilities

DailyMed offers a straightforward basic search functionality accessible via a prominent search bar on its homepage and throughout the site, allowing users to query the database by drug name, National Drug Code (NDC), manufacturer, , or Set ID to retrieve relevant drug labels. This site-wide search supports queries and is designed for quick access to prescribing information, with results displaying key details such as product summaries and links to full labels. For more precise queries, the advanced search enables users to target specific fields using operators (, NOT IN), exact phrases in quotes, and wildcards (*), with options to restrict results to drugs, drugs, or all products. Available search fields include drug name, NDC code, application number, Set ID, document , drug class (therapeutic classes), active moiety, UNII code, inactive ingredient UNII code, and inactive ingredients, facilitating detailed lookups by unique identifiers like UNII for active and inactive components. These enhancements, introduced in 2015, allow for refined searches on chemical and pharmacological attributes without requiring full product knowledge. Integration with the FDA's Orange Book occurs via searchable application numbers, which correspond to approved drug entries in the Orange Book, allowing cross-referencing of generic equivalents, patents, and therapeutic equivalence ratings directly from DailyMed results. The separate FDALabel tool, powered by data from DailyMed's SPL files, enables searches within specific sections of drug labels, such as adverse reactions (using LOINC code 34084-4), warnings and precautions, dosage and administration, or contraindications. For example, querying "adverse reactions" within a specific drug's label retrieves targeted excerpts, aiding healthcare professionals in rapid risk assessment. Accessibility features ensure broad usability, with the search interface compatible with screen readers and assistive technologies, adhering to Section 508 standards; the 2014 redesign introduced responsive design for mobile and desktop access without compromising functionality. Users can report accessibility issues, and the system supports major browsers like and for optimal performance.

Data Formats and Download Options

DailyMed provides users with multiple formats for viewing drug labeling information, including for an interactive, web-based readable presentation, PDF for printable and portable document versions, and XML in Labeling (SPL) format for machine-readable structured data. These options allow flexibility for different user needs, such as casual browsing in , professional printing in PDF, or programmatic processing via XML/SPL. For bulk access, DailyMed offers periodic downloads of the entire dataset, including daily, weekly, and monthly updates as well as full releases, all provided as files containing XML-formatted labels along with indexing and mapping files. These archives enable comprehensive data retrieval for research, integration into databases, or offline analysis without requiring individual searches. Programmatic retrieval is supported through the Library of Medicine's (NLM) RESTful (version 2), which allows developers to query and access current SPL data in XML or formats via endpoints for resources like drug names, Drug Codes (NDCs), and specific labels. Additionally, feeds notify users of new or updated drug labels approved by the FDA and published on DailyMed, with per-label options available for tracking changes to individual products. Historical and versioned access is maintained through the Labeling Archives, where users can retrieve labels that were current on a specific date, supporting and longitudinal studies of labeling changes; by default, archives display only the current year's data, with older versions accessible via search or support requests.

Technical Infrastructure

Data Submission Process

Manufacturers of prescription drugs, over-the-counter medications, biologics, and certain other products regulated by the FDA are required to submit product labeling in Labeling (SPL) format to the FDA upon initial approval of a or . This mandatory submission ensures that essential scientific and regulatory information, such as indications, dosage, warnings, and adverse reactions, is captured in a standardized format compliant with Health Level Seven (HL7) standards. Subsequent SPL submissions are required for any significant changes to approved labeling, including updates for new safety information, expanded indications, or post-marketing surveillance findings that necessitate revisions. Additionally, manufacturers must submit annual reports detailing any labeling changes or certify that no modifications have occurred, typically within a three-month window following the end of the calendar year. These submissions are transmitted securely through the FDA's Electronic Submissions Gateway (), a centralized platform designed to handle electronic regulatory filings with and protocols to protect sensitive data. Upon receipt via ESG, the FDA conducts validation and processing of the SPL files to ensure compliance with labeling regulations under the Food, Drug, and Cosmetic Act, including checks for format accuracy, completeness, and adherence to content requirements. Validated submissions are then forwarded by the FDA to the of Medicine (NLM), which hosts the data on DailyMed for public dissemination. This process maintains the integrity of the labeling information entering the system while facilitating timely updates in response to evolving product safety profiles or regulatory decisions.

Update Mechanisms and Reliability

DailyMed maintains a daily publication cycle for new and updated drug labels, processing FDA-approved submissions and posting them within 24 hours of receipt by the National Library of Medicine (NLM) from the (FDA), following sponsors' submission of Structured Product Labeling (SPL) files to the FDA after approval. "In use" labels, which reflect the versions currently marketed by manufacturers, are submitted by companies to the FDA, which forwards them to NLM and incorporated promptly to ensure the database captures the most recent market-available information, with periodic updates available daily, weekly, or monthly through downloadable files. This cycle prioritizes timeliness while adhering to SPL format standardization for consistent data exchange. Reliability is enhanced through FDA's of for regulated submissions, ensuring clinical accuracy and safety for approved labels, while NLM performs validation to confirm compliance with SPL structural requirements before , without substantive . Prior versions of labels are archived to allow tracking of changes over time, preserving historical data for reference and enabling users to view as it was on specific past dates. Although "in use" labels may not undergo FDA verification, the system relies on manufacturers' responsibility for accuracy under regulatory mandates. Notification systems include feeds that deliver updates on new and revised labels from the past seven days directly to users' desktops, browsers, or email via compatible readers, supporting real-time awareness of changes. Specific drug labels can be monitored through dedicated feeds obtained via the search . DailyMed integrates with FDA communications by incorporating updates related to emerging risks, such as those from safety labeling changes, into its . Each label features an via a unique set ID that remains consistent across revisions, along with the submission date and effective time embedded in the SPL , allowing verification of authenticity and chronology. Version history for any set ID is accessible through web services, providing a complete record of all prior iterations to support and .

Impact and Significance

Role in Public Health and Healthcare

DailyMed plays a crucial role in facilitating evidence-based prescribing by offering healthcare providers access to comprehensive, FDA-vetted labeling, including prescribing information that details indications, dosages, contraindications, warnings, precautions, adverse reactions, and interactions. This structured access helps clinicians make informed decisions to minimize prescribing errors and optimize outcomes. For instance, the platform's searchable database enables quick retrieval of up-to-date labels, supporting safer management across various settings. In , DailyMed supports ongoing drug safety monitoring by disseminating current "in use" labeling submitted to the FDA, which incorporates updates on and risk mitigations derived from post-marketing surveillance. These label revisions, reflecting emerging safety data, allow providers and regulators to track and respond to potential risks, complementing systems like the FDA Adverse Event Reporting System (FAERS) through integrated access to authoritative information. By ensuring widespread availability of these updates, DailyMed contributes to the timely identification and communication of drug-related hazards. DailyMed enhances and training for healthcare providers by serving as a reliable repository of detailed drug information essential for and . It is utilized in clinical training programs to teach safe prescribing practices, recognition, and patient counseling techniques, with resources like Medication Guides aiding in direct communication. This educational utility promotes adherence to FDA guidelines and reduces medication errors through informed practice. On a broader scale, DailyMed advances by providing accessible drug information during health crises, such as through rapid publication of labeling during the , which informed efforts and outbreak responses. The platform's user-friendly formats, including views and patient-directed Drug Facts labels, foster among the public and providers, empowering informed decision-making and equitable access to medication knowledge. In collaboration with the FDA, DailyMed ensures this information remains trustworthy and current, bolstering overall healthcare resilience.

Usage Statistics and Adoption

DailyMed attracts millions of annual visits, with over 12 million unique visitors recorded in fiscal year 2017 alone, reflecting its role as a key resource for drug labeling information. Usage has shown peaks during health crises, such as the COVID-19 pandemic, when the database rapidly incorporated and disseminated labeling for vaccines like COMIRNATY and SPIKEVAX, driving heightened access to updated product information amid widespread vaccine rollouts. Its free public availability has significantly contributed to broad adoption across healthcare sectors. Primary users include pharmacists, physicians, patients, and researchers, who rely on DailyMed for accurate, up-to-date FDA-approved drug labels to support clinical decision-making, , and . While specific demographic breakdowns from NLM analytics up to 2025 are not publicly detailed, the platform's design caters to these groups through searchable interfaces and downloadable content tailored to professional and consumer needs. Adoption in electronic health records (EHRs) is facilitated by DailyMed's RESTful , which enables programmatic access to structured product labeling (SPL) data for integration into systems like and Cerner, allowing seamless incorporation of drug information into clinical workflows. This supports bulk data retrieval and real-time updates, enhancing medication management in healthcare settings. Although primarily U.S.-focused on FDA-regulated products, DailyMed sees international use for accessing American drug information, with bulk download options available in formats like XML zip files for daily, weekly, monthly, or full releases. These downloads, exceeding tens of thousands annually based on historical NLM resource utilization patterns, support global research and health information systems.

References

  1. [1]
    About DailyMed - NIH
    The DailyMed database contains labeling, submitted to the Food and Drug Administration (FDA) by companies, for the following products.Missing: official | Show results with:official
  2. [2]
    DailyMed® Logs 500th Label. NLM Technical Bulletin. 2006 Jul–Aug
    Aug 20, 2025 · DailyMed provides a standard, up-to-date source for look-up and download of drug information found in medication package inserts for use by ...
  3. [3]
    [PDF] Guidance for Industry - Public Availability of Labeling Changes in ...
    Sep 18, 2006 · FDA will make labeling revisions from CBE supplements publicly available upon receipt, but this is not an endorsement of the revised labeling.Missing: creation | Show results with:creation
  4. [4]
    Draft Guidance for Industry on Public Availability of Labeling ...
    Sep 20, 2006 · To make the most current labeling submitted to FDA available to health care practitioners and the public, and to facilitate the DailyMed ...Missing: creation | Show results with:creation
  5. [5]
    Wei Ma Selected to Serve as Acting Director, Office of Computer and ...
    Dec 13, 2022 · Wei Ma has been selected to serve as Acting Director, Office of Computer and Communication Systems (OCCS) at the National Library of Medicine (NLM).Missing: governance | Show results with:governance
  6. [6]
    . NLM Technical Bulletin. 2006 Jul–Aug - National Library of Medicine
    Aug 4, 2006 · DailyMed, the Web site created in November 2005 by the National Library of Medicine® (NLM) in cooperation with the Food and Drug Administration ...Missing: launch history beta
  7. [7]
    DailyMed Web Site Now Available. NLM Technical Bulletin. 2006 ...
    Mar 7, 2006 · On November 1, the first label was transmitted to NLM for publication. The practice of the FDA is to review and approve each label every year.Missing: history beta
  8. [8]
    Structured Product Labeling Resources - FDA
    Jan 8, 2025 · The Structured Product Labeling (SPL) is a document markup standard approved by Health Level Seven (HL7) and adopted by FDA as a mechanism for exchanging ...
  9. [9]
    The U.S. National Library of Medicine and standards for electronic ...
    Mar 4, 2022 · In November 2005, NLM released DailyMed, the official distribution mechanism for current SPLs submitted to FDA by companies [45]. By mid-2002, ...
  10. [10]
    DailyMed Product Identification System. NLM Technical Bulletin ...
    May 11, 2009 · This system is intended to help users identify solid dose form products (tablets and capsules) by their description and assist them in identifying medications ...Missing: NDC | Show results with:NDC
  11. [11]
    DailyMed Mobile Version Launched. NLM Technical Bulletin. 2011 ...
    Mar 4, 2011 · NLM® released DailyMed® Mobile on January 31, 2011. DailyMed provides access to over 20000 structured product labels (SPL) from the Food and ...
  12. [12]
    News: DailyMed Announcements
    Sep 26, 2014 · DailyMed is the official provider of Food and Drug Administration (FDA) label information. The Web site provides a standard, comprehensive, up-to-date, look-up ...
  13. [13]
    News: DailyMed Announcements
    Apr 15, 2015 · DailyMed Interface Updated for Quicker and Easier Searching · UNIIs, Inactive Ingredients, and Active Moieties Added to DailyMed Advanced Search.Missing: redesign 2014
  14. [14]
    Resource Spotlight: DailyMed – Region 4 News
    Jul 31, 2025 · DailyMed is the official provider of FDA label information (package inserts) for over 154,000 drugs marketed in the United States, including ...Missing: mission | Show results with:mission
  15. [15]
    FLULAVAL 2025/2026- influenza virus vaccine suspension - DailyMed
    FLULAVAL is indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.Clinical Trials Experience · Postmarketing Experience · Pregnancy · DESCRIPTION
  16. [16]
    RSS Updates - DailyMed - NIH
    DailyMed will deliver notification of updates and additions to Drug Label information currently shown on this site through its RSS feed. DailyMed will deliver ...
  17. [17]
    SPL RESOURCES: Download All Drug Labels - DailyMed
    Choose from daily, weekly or monthly periodic updates or full releases of all drug labels. Downloads are available as zip files.
  18. [18]
    Help - DailyMed
    The search allows you to search by drug name, NDC code, manufacturer name, drug class or SET ID. The search functionality is available on the home page.Missing: governance | Show results with:governance
  19. [19]
    News: DailyMed Announcements
    Oct 19, 2017 · Users can now search DailyMed by unique ingredient identifier (UNII) for an active ingredient and an active moiety.
  20. [20]
    News: DailyMed Announcements - NIH
    The RxImage API will cease operation on December 31, 2021. DailyMed will be removing pill images provided by the RxImage API on October 31, 2021. Pill images ...
  21. [21]
    DailyMed
    Sep 15, 2021 · DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, ...Advanced Search · Download All Drug Labels · Help · About
  22. [22]
    FDA's Labeling Resources for Human Prescription Drugs
    Jul 1, 2025 · FDA's labeling resources for human prescription drugs are primarily directed to industry staff who develop human prescription drug labeling.Prescribing Information · Prescription Medicines · Patient Labeling Resources<|separator|>
  23. [23]
    FDA Label Search
    You can search for labels by drug name and link to the Library's information resources about marketed drugs.
  24. [24]
    Advanced Search - DailyMed - NIH
    Active Ingredient UNII Code, Inactive Ingredient UNII Code, Any UNII Code, --Ingredients--, Active Ingredient, Inactive Ingredient ... Recent Major Changes ...Missing: redesign 2014
  25. [25]
    FDALabel: Full-Text Search of Drug Product Labeling | FDA
    Dec 17, 2024 · FDALabel is a web-based application for customizable full-text searches of over 150,000 FDA-approved drug labeling documents.
  26. [26]
  27. [27]
    SPL Resources: Download Data - DailyMed
    Choose from daily, weekly or monthly periodic updates or full releases of all drug labels. Downloads are available as zip files. Download XML indexing and REMS ...Missing: feeds | Show results with:feeds
  28. [28]
    Application Development Support: Web Services - DailyMed - NIH
    View the history of updates to this API. Returns a list of all NDA numbers. The base URI for the web services is: https://dailymed.nlm.nih.gov/dailymed/services ...Missing: milestones | Show results with:milestones
  29. [29]
    Labeling Archives - DailyMed - NIH
    This archive allows the user to retrieve the label current for a given date. By default, only archived labels for this year are returned.
  30. [30]
    Safety Labeling Change Orders - FDA
    FDA requires labeling changes based on new safety information. After notification, the applicant must submit proposed changes or a rebuttal. FDA can issue an ...
  31. [31]
    Electronic Drug Registration and Listing Instructions - FDA
    Jun 7, 2023 · Users may transmit the SPL-formatted submission through FDA's electronic submission gateway (ESG).
  32. [32]
  33. [33]
    [PDF] Structured Product Labeling (SPL) Implementation Guide with ... - FDA
    ... UNII code or EPA SRS tracking number. 19.2.3.2 There is one substance code. 19.2.3.3 Code system is 2.16.840.1.113883.4.9 (UNII) or 2.16.840.1.113883.6.275 (EPA.
  34. [34]
    RESTful Web Services - /spls/{SETID}/history - DailyMed
    Browse Drug Classes, Labeling Archives, Application Development Support: Web Services: RESTful Resources Returns version history for the specified SET ID.Missing: bulk capabilities
  35. [35]
    Postmarket Drug Safety Information for Patients and Providers - FDA
    Jun 11, 2025 · DailyMed - NIH's labeling tool designed to search over 140,000 labeling documents for prescription drugs (including “small molecules”, ...
  36. [36]
    Summary | Preventing Medication Errors
    This report provides guidance on how to implement error prevention strategies in hospitals, long-term care, and ambulatory care.
  37. [37]
    MOU 225-12-0020 - FDA
    Dec 15, 2017 · The DailyMed Initiative is a partnership between the FDA and the National Library of Medicine (NLM). Drug manufacturers and distributors provide ...
  38. [38]
    [PDF] National Library of Medicine 2017 Annual Report - NIH
    Sep 30, 2018 · NLM awarded 140 grant awards this year, 58 of them new grant awards . In addition to grants funded with NLM's appropriated funds, EP.Missing: governance | Show results with:governance
  39. [39]
    DailyMed
    ### Summary of DailyMed Search Capabilities
  40. [40]
    RESTful Web Services - /spls - DailyMed - NIH
    The service returns a list of all Structured Product Labels (SPLs) in XML or JSON format.